MeiraGTx Holdings (MGTX) Shareholder's Equity Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.02% |
| Sep 30, 2025 | -32.58% |
| Jun 30, 2025 | -72.48% |
| Mar 31, 2025 | -41.02% |
| Dec 31, 2024 | -28.48% |
| Sep 30, 2024 | -20.12% |
| Jun 30, 2024 | -27.00% |
| Mar 31, 2024 | -18.00% |
| Dec 31, 2023 | -16.64% |
| Sep 30, 2023 | -19.94% |
| Jun 30, 2023 | -10.58% |
| Mar 31, 2023 | -21.28% |
| Dec 31, 2022 | -14.86% |
| Sep 30, 2022 | -14.30% |
| Jun 30, 2022 | 3.10% |
| Mar 31, 2022 | 3.75% |
| Dec 31, 2021 | 31.76% |
| Sep 30, 2021 | 24.93% |
| Jun 30, 2021 | 23.78% |
| Mar 31, 2021 | 77.84% |
| Dec 31, 2020 | 91.63% |